Cash flow GMO Payment Gateway, Inc.

Equities

3769

JP3385890003

Business Support Services

Market Closed - Japan Exchange Other stock markets 06:30:00 05/12/2025 GMT			5-day change	1st Jan Change
10,150.00 ^JPY	-1.12%		+1.10%	+27.34%

11-13	GMO Payment Gateway, Inc. Provides Consolidated Earnings Guidance for the Six Months Ending March 31, 2026 and Full Fiscal Year Ending September 30, 2026	CI
11-13	GMO Payment Gateway, Inc. Announces Cash Dividend for the Fiscal Year Ended September 30, 2025, Payable on December 16, 2025; Provides Dividend Guidance for the Fiscal Year Ending September 30, 2026	CI

0f.IRPLoQLe92Z_55B46mQLUipUobHvizCVOmnITiqrmzs.UiOe2zCItidHuPdOgBw7CEIglIec8gfMfza4eUn0w2tKXY7PS427DheTxQ

Published financial data: GMO PAYMENT GATEWAY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020	2021	2022	2023	2024
Revenues	33.05B	41.67B	50.3B	63.12B	73.78B
Total Revenues	33.05B	41.67B	50.3B	63.12B	73.78B
Cost of Goods Sold, Total	9.2B	13.57B	16.66B	23.13B	25.68B
Gross Profit	23.85B	28.1B	33.64B	39.98B	48.1B
Selling General & Admin Expenses, Total	10.62B	12.2B	14.26B	15.75B	19.84B
Provision for Bad Debts	2.1B	1.97B	2.4B	3.06B	2.19B
Depreciation & Amortization - (IS)	710M	862M	945M	-	1.2B
Other Operating Expenses	-106M	-248M	-265M	795M	-348M
Other Operating Expenses, Total	13.32B	14.78B	17.34B	19.6B	22.88B
Operating Income	10.53B	13.32B	16.3B	20.38B	25.22B
Interest Expense, Total	-173M	-151M	-180M	-233M	-288M
Interest And Investment Income	35M	36M	223M	993M	1.12B
Net Interest Expenses	-138M	-115M	43M	760M	837M
Income (Loss) On Equity Invest.	517M	17M	184M	107M	181M
Currency Exchange Gains (Loss)	-42M	7M	975M	-495M	-37M
Other Non Operating Income (Expenses)	-37M	-50M	-46M	-71M	-111M
EBT, Excl. Unusual Items	10.83B	13.17B	17.45B	20.68B	26.09B
Gain (Loss) On Sale Of Investments	-92M	-	16.93B	-	1.63B
Gain (Loss) On Sale Of Assets	301M	415M	371M	-50M	-216M
Asset Writedown	-50M	-305M	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	10.99B	13.28B	34.76B	20.64B	27.5B
Income Tax Expense	3.12B	4.3B	10.4B	6.81B	8.27B
Earnings From Continuing Operations	7.87B	8.98B	24.36B	13.82B	19.23B
Earnings Of Discontinued Operations	-179M	-	-	-	-
Net Income to Company	7.69B	8.98B	24.36B	13.82B	19.23B
Minority Interest	-69M	-164M	-208M	-347M	-529M
Net Income - (IS)	7.62B	8.82B	24.15B	13.48B	18.7B
Net Income to Common Incl Extra Items	7.62B	8.82B	24.15B	13.48B	18.7B
Net Income to Common Excl. Extra Items	7.8B	8.82B	24.15B	13.48B	18.7B
Per Share Items
Net EPS - Basic	103.62	117.97	318.45	177.67	246.62
Basic EPS - Continuing Operations	106.05	117.97	318.45	177.67	246.62
Basic Weighted Average Shares Outstanding	73.58M	74.75M	75.84M	75.84M	75.85M
Net EPS - Diluted	100.93	116.17	314.66	175.86	243.85
Diluted EPS - Continuing Operations	103.29	116.17	314.66	175.86	243.85
Diluted Weighted Average Shares Outstanding	75.83M	76.17M	76.94M	76.95M	76.95M
Normalized Basic EPS	91.05	107.96	141.08	165.88	208.02
Normalized Diluted EPS	88.34	105.94	139.07	163.51	205.03
Dividend Per Share	52	59	79	89	116
Payout Ratio	34.73	43.39	18.51	90	36.07
Supplemental Items
EBITDA	12.05B	15.21B	18.44B	22.8B	28.57B
EBITA	10.53B	13.32B	16.3B	20.38B	25.22B
EBIT	10.53B	13.32B	16.3B	20.38B	25.22B
Effective Tax Rate - (Ratio)	28.36	32.38	29.91	33.02	30.07
Normalized Net Income	6.7B	8.07B	10.7B	12.58B	15.78B
Non-Cash Pension Expense	97M	118M	134M	174M	183M
Supplemental Operating Expense Items
Advertising Expense	-	-	988M	-	1.17B
Selling and Marketing Expenses	-	-	988M	-	1.17B

Fiscal Period: September	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	95.83B	105B	114B	134B	174B
Short Term Investments	5B	2B	16.5B	5.3B	-
Total Cash And Short Term Investments	101B	107B	130B	139B	174B
Accounts Receivable, Total	10.78B	10.31B	13.96B	18.95B	21.11B
Other Receivables	23.58B	24.89B	30.33B	33.4B	37.49B
Total Receivables	34.37B	35.2B	44.3B	52.35B	58.6B
Inventory	1.44B	1.66B	1.53B	2.4B	3.18B
Prepaid Expenses	-	-	-	-	-
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	32.74B	46.12B	67.96B	64.76B	62.26B
Total Current Assets	169B	190B	244B	258B	298B
Net Property Plant And Equipment	3.71B	3.95B	3.54B	3.35B	3.92B
Long-term Investments	12.54B	14.95B	17.32B	19.52B	29.27B
Goodwill	1.16B	1.26B	1.26B	1.26B	1.26B
Other Intangibles, Total	3.69B	4.26B	5.69B	8.05B	9.78B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.53B	1.53B	1.34B	1.7B	2.38B
Other Long-Term Assets, Total	2M	1M	2M	1M	2M
Total Assets	192B	215B	273B	292B	345B
Liabilities
Accounts Payable, Total	4.3B	5.23B	5.6B	6.56B	8.02B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	18B	15B	17B	19.9B	23.8B
Current Portion of Long-Term Debt	800M	138M	-	495M	540M
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	21.88B	23.14B	28.2B	33.26B	30.04B
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	91.2B	89.21B	97.03B	103B	142B
Total Current Liabilities	136B	133B	148B	163B	204B
Long-Term Debt	16.94B	19.61B	25.68B	28.72B	28.76B
Long-Term Leases	-	-	-	-	-
Deferred Tax Liability Non Current	54M	78M	5.64B	1.22B	1.42B
Other Non Current Liabilities	5.4B	5.23B	5.01B	4.31B	4.34B
Total Liabilities	159B	158B	184B	198B	239B
Common Stock, Total	4.71B	13.32B	13.32B	13.32B	13.32B
Additional Paid In Capital	5.68B	15.19B	15.27B	15.25B	15.2B
Retained Earnings	20.72B	26.55B	49.42B	50.77B	62.71B
Treasury Stock	-1.15B	-1.15B	-1.15B	-1.15B	-1.12B
Comprehensive Income and Other	1.77B	1.94B	10.26B	14.09B	12.77B
Total Common Equity	31.73B	55.84B	87.12B	92.27B	103B
Minority Interest	1.72B	1.97B	2.14B	2.53B	2.92B
Total Equity	33.45B	57.82B	89.26B	94.8B	106B
Total Liabilities And Equity	192B	215B	273B	292B	345B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	73.65M	75.84M	75.84M	75.84M	75.85M
ECS Total Common Shares Outstanding	73.59M	75.84M	75.84M	75.84M	75.85M
Book Value / Share	431.24	736.33	1.15K	1.22K	1.36K
Tangible Book Value	26.88B	50.32B	80.18B	82.96B	91.86B
Tangible Book Value Per Share	365.27	663.53	1.06K	1.09K	1.21K
Total Debt	35.74B	34.75B	42.68B	49.11B	53.1B
Net Debt	-65.08B	-71.77B	-87.79B	-89.84B	-121B
Minority Interest, Total (Incl. Fin. Div)	1.72B	1.97B	2.14B	2.53B	2.92B
Equity Method Investments, Total	3.74B	4.59B	8.61B	9.19B	9.54B
Inventories - Finished Goods, Total	1.43B	1.62B	1.51B	2.4B	3.18B
Inventories - Others	8M	49M	25M	3M	4M
Full Time Employees	625	714	799	825	853
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: September	2020	2021	2022	2023	2024
Net Income	10.99B	13.28B	34.76B	20.64B	27.5B
Depreciation & Amortization - CF	1.52B	1.9B	2.15B	2.41B	3.35B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	1.52B	1.9B	2.15B	2.41B	3.35B
(Gain) Loss From Sale Of Asset	115M	187M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	172M	-	-16.93B	-	-1.63B
(Income) Loss On Equity Investments - (CF)	-517M	-17M	-184M	-107M	-181M
Net Cash From Discontinued Operations	-158M	-	-	-	-
Other Operating Activities, Total	-3.27B	-5.03B	-6.6B	-8.33B	-13.41B
Change In Accounts Receivable	-530M	-1.5B	-1.62B	-4.62B	-5.81B
Change In Inventories	-1.23B	-223M	132M	-872M	-776M
Change In Accounts Payable	4.81B	1.76B	2.76B	3.26B	3.41B
Change in Other Net Operating Assets	37.29B	-16.71B	-6.81B	-6.25B	37.01B
Cash from Operations	49.19B	-6.34B	7.66B	6.13B	49.47B
Capital Expenditure	-428M	-245M	-321M	-529M	-495M
Cash Acquisitions	-	-108M	-500M	-	-400M
Divestitures	-968M	-	-	-	-
Sale (Purchase) of Intangible assets	-1.51B	-1.68B	-2.65B	-4.1B	-3.95B
Investment in Marketable and Equity Securities, Total	-884M	395M	12.52B	10.98B	-5.79B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-705M	3.86B	-11.5B	11.41B	5.41B
Cash from Investing	-4.49B	2.23B	-2.44B	17.76B	-5.23B
Short Term Debt Issued, Total	3B	-	2B	2.9B	3.9B
Long-Term Debt Issued, Total	-	21.06B	6B	3.45B	500M
Total Debt Issued	3B	21.06B	8B	6.35B	4.4B
Short Term Debt Repaid, Total	-	-3.02B	-	-	-
Long-Term Debt Repaid, Total	-1.27B	-803M	-159M	-	-495M
Total Debt Repaid	-1.27B	-3.82B	-159M	-	-495M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-2.65B	-3.83B	-4.47B	-12.13B	-6.75B
Common & Preferred Stock Dividends Paid	-2.65B	-3.83B	-4.47B	-12.13B	-6.75B
Other Financing Activities, Total	130M	-627M	-735M	-641M	-887M
Cash from Financing	-785M	12.78B	2.64B	-6.42B	-3.73B
Foreign Exchange Rate Adjustments	-93M	23M	1.6B	2.22B	-116M
Miscellaneous Cash Flow Adjustments	-	2M	-1M	1M	-2M
Net Change in Cash	43.82B	8.69B	9.44B	19.69B	40.4B
Supplemental Items
Cash Interest Paid	169M	138M	98M	149M	207M
Cash Income Tax Paid (Refund)	3.04B	4.65B	5.23B	9.01B	13.87B
Levered Free Cash Flow	48.09B	-6.02B	-8.31B	16.74B	47.08B
Unlevered Free Cash Flow	48.2B	-5.93B	-8.2B	16.88B	47.26B
Change In Net Working Capital	-42.04B	14.22B	17.56B	-6.36B	-32.59B
Net Debt Issued / Repaid	1.73B	17.23B	7.84B	6.35B	3.9B

Fiscal Period: September	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.96	4.08	4.17	4.5	4.95
Return on Total Capital	10.05	10.29	9.07	9.24	10.41
Return On Equity %	25.81	19.68	33.13	15.02	19.17
Return on Common Equity	26.8	20.14	33.79	15.02	19.17
Margin Analysis
Gross Profit Margin %	72.16	67.43	66.87	63.35	65.19
SG&A Margin	32.13	29.27	28.35	24.95	26.89
EBITDA Margin %	36.46	36.51	36.67	36.12	38.72
EBITA Margin %	31.86	31.96	32.4	32.29	34.18
EBIT Margin %	31.86	31.96	32.4	32.29	34.18
Income From Continuing Operations Margin %	23.82	21.56	48.43	21.9	26.07
Net Income Margin %	23.07	21.16	48.02	21.35	25.35
Net Avail. For Common Margin %	23.61	21.16	48.02	21.35	25.35
Normalized Net Income Margin	20.27	19.37	21.27	19.93	21.38
Levered Free Cash Flow Margin	145.53	-14.45	-16.53	26.51	63.8
Unlevered Free Cash Flow Margin	145.86	-14.23	-16.31	26.74	64.04
Asset Turnover
Asset Turnover	0.2	0.2	0.21	0.22	0.23
Fixed Assets Turnover	15.62	10.88	13.43	18.31	20.29
Receivables Turnover (Average Receivables)	2.7	3.95	4.14	3.84	3.68
Inventory Turnover (Average Inventory)	11.17	8.74	10.43	11.75	9.19
Short Term Liquidity
Current Ratio	1.24	1.43	1.65	1.58	1.46
Quick Ratio	0.99	1.07	1.18	1.17	1.14
Operating Cash Flow to Current Liabilities	0.36	-0.05	0.05	0.04	0.24
Days Sales Outstanding (Average Receivables)	135.37	92.37	88.07	95.17	99.36
Days Outstanding Inventory (Average Inventory)	32.76	41.75	35	31.06	39.81
Average Days Payable Outstanding	157.6	126.04	119.51	92.36	100.8
Cash Conversion Cycle (Average Days)	10.54	8.08	3.56	33.87	38.37
Long Term Solvency
Total Debt/Equity	106.85	60.1	47.81	51.8	50.18
Total Debt / Total Capital	51.66	37.54	32.35	34.13	33.42
LT Debt/Equity	50.65	33.92	28.77	30.29	27.18
Long-Term Debt / Total Capital	24.49	21.19	19.46	19.95	18.1
Total Liabilities / Total Assets	82.58	73.16	67.35	67.57	69.3
EBIT / Interest Expense	60.86	88.18	90.53	87.48	87.57
EBITDA / Interest Expense	69.65	100.74	102.47	97.84	99.19
(EBITDA - Capex) / Interest Expense	67.17	99.11	100.68	95.57	97.47
Total Debt / EBITDA	2.97	2.28	2.31	2.15	1.86
Net Debt / EBITDA	-5.4	-4.72	-4.76	-3.94	-4.23
Total Debt / (EBITDA - Capex)	3.08	2.32	2.35	2.21	1.89
Net Debt / (EBITDA - Capex)	-5.6	-4.8	-4.84	-4.03	-4.31
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.88	26.09	20.71	25.49	16.9
Gross Profit, 1 Yr. Growth %	16.3	17.83	19.71	18.88	20.3
EBITDA, 1 Yr. Growth %	14.11	26.24	21.25	23.6	25.31
EBITA, 1 Yr. Growth %	11.47	26.46	22.39	25.09	23.72
EBIT, 1 Yr. Growth %	11.47	26.46	22.39	25.09	23.72
Earnings From Cont. Operations, 1 Yr. Growth %	55.82	14.1	171.21	-43.26	39.15
Net Income, 1 Yr. Growth %	44.75	15.66	173.89	-44.21	38.81
Normalized Net Income, 1 Yr. Growth %	14.16	20.46	32.59	17.59	25.4
Diluted EPS Before Extra, 1 Yr. Growth %	47.37	12.46	170.87	-44.11	38.66
Accounts Receivable, 1 Yr. Growth %	-21.09	-4.4	35.47	35.73	11.38
Inventory, 1 Yr. Growth %	595.65	15.56	-7.93	56.98	32.31
Net Property, Plant and Equip., 1 Yr. Growth %	618.38	6.3	-10.28	-5.34	16.91
Total Assets, 1 Yr. Growth %	37.17	12.2	26.9	6.93	17.91
Tangible Book Value, 1 Yr. Growth %	21.44	87.22	59.33	3.47	10.73
Common Equity, 1 Yr. Growth %	19.78	75.98	56.01	5.91	11.51
Cash From Operations, 1 Yr. Growth %	3.65K	-112.9	-220.7	-19.96	707.31
Capital Expenditures, 1 Yr. Growth %	174.36	-42.76	31.02	64.8	-6.43
Levered Free Cash Flow, 1 Yr. Growth %	24.87K	-112.52	38.06	-301.28	181.29
Unlevered Free Cash Flow, 1 Yr. Growth %	18.04K	-112.3	38.36	-305.82	179.93
Dividend Per Share, 1 Yr. Growth %	44.44	13.46	33.9	12.66	30.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.85	13.89	23.37	23.08	21.12
Gross Profit, 2 Yr. CAGR %	17.28	17.06	18.76	19.29	19.59
EBITDA, 2 Yr. CAGR %	23.13	20.02	23.72	22.42	24.45
EBITA, 2 Yr. CAGR %	22.79	18.73	24.41	23.73	24.4
EBIT, 2 Yr. CAGR %	22.79	18.73	24.41	23.73	24.4
Earnings From Cont. Operations, 2 Yr. CAGR %	36.14	33.34	75.91	24.05	-11.14
Net Income, 2 Yr. CAGR %	33.86	29.39	77.99	23.62	-12
Normalized Net Income, 2 Yr. CAGR %	26.16	17.27	26.38	24.86	21.43
Diluted EPS Before Extra, 2 Yr. CAGR %	34.08	28.74	74.54	23.04	-11.97
Accounts Receivable, 2 Yr. CAGR %	-9.74	-13.14	13.8	35.6	22.95
Inventory, 2 Yr. CAGR %	374.34	183.53	3.14	20.22	44.12
Net Property, Plant and Equip., 2 Yr. CAGR %	187.29	176.34	-2.34	-7.84	5.2
Total Assets, 2 Yr. CAGR %	28.19	24.06	19.32	16.49	12.28
Tangible Book Value, 2 Yr. CAGR %	16.33	50.78	72.71	28.4	7.04
Common Equity, 2 Yr. CAGR %	13.13	45.19	65.69	28.54	8.68
Cash From Operations, 2 Yr. CAGR %	223.47	119.96	-60.55	-1.71	154.2
Capital Expenditures, 2 Yr. CAGR %	135.76	25.32	-13.4	46.94	24.18
Levered Free Cash Flow, 2 Yr. CAGR %	291.18	459.15	-58.42	66.7	137.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	289.42	372.3	-58.75	68.75	140.03
Dividend Per Share, 2 Yr. CAGR %	33.91	28.02	23.26	22.82	21.18
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.88	16.4	16.12	24.07	20.98
Gross Profit, 3 Yr. CAGR %	16.44	17.46	17.94	18.8	19.63
EBITDA, 3 Yr. CAGR %	26.74	24.16	20.43	23.68	23.38
EBITA, 3 Yr. CAGR %	26.74	24	19.93	24.63	23.73
EBIT, 3 Yr. CAGR %	28.05	24	19.93	24.63	23.73
Earnings From Cont. Operations, 3 Yr. CAGR %	38.21	28.36	68.94	20.64	28.89
Net Income, 3 Yr. CAGR %	37.26	27.49	66.14	20.91	28.49
Normalized Net Income, 3 Yr. CAGR %	31.77	24.23	22.17	23.38	25.04
Diluted EPS Before Extra, 3 Yr. CAGR %	37.56	26.45	64.96	19.41	28.04
Accounts Receivable, 3 Yr. CAGR %	1.58	-8	0.73	20.69	26.99
Inventory, 3 Yr. CAGR %	148.36	196.25	94.88	18.65	24.12
Net Property, Plant and Equip., 3 Yr. CAGR %	110.36	106.25	89.93	-3.35	-0.24
Total Assets, 3 Yr. CAGR %	32.19	22.62	25	15.04	16.96
Tangible Book Value, 3 Yr. CAGR %	18.66	36.33	53.58	45.6	22.21
Common Equity, 3 Yr. CAGR %	15.51	31.08	48.71	42.73	22.59
Cash From Operations, 3 Yr. CAGR %	204.1	10.5	80.08	-50.06	98.31
Capital Expenditures, 3 Yr. CAGR %	62.91	47.08	27.19	7.32	26.42
Levered Free Cash Flow, 3 Yr. CAGR %	272.66	24.21	250.79	-29.66	98.46
Unlevered Free Cash Flow, 3 Yr. CAGR %	270.54	23.09	213.68	-29.51	99.76
Dividend Per Share, 3 Yr. CAGR %	37.51	26.71	29.95	19.62	25.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	29.62	28.03	18.21	19.03	18.1
Gross Profit, 5 Yr. CAGR %	27.38	24.63	17.36	18.19	18.6
EBITDA, 5 Yr. CAGR %	29.78	29.42	25.53	23.46	22.02
EBITA, 5 Yr. CAGR %	28.7	28.36	25.8	23.89	21.7
EBIT, 5 Yr. CAGR %	28.74	28.37	26.58	23.89	21.7
Earnings From Cont. Operations, 5 Yr. CAGR %	33.58	25.28	52.21	26.62	30.65
Net Income, 5 Yr. CAGR %	32.7	24.82	52.29	25.93	28.85
Normalized Net Income, 5 Yr. CAGR %	28.97	27.85	29.59	24.48	21.87
Diluted EPS Before Extra, 5 Yr. CAGR %	31.48	24.29	51.31	25.07	28.32
Accounts Receivable, 5 Yr. CAGR %	20.61	-1.09	6.3	7.44	9.09
Inventory, 5 Yr. CAGR %	328.23	111.84	74.75	106.53	72.72
Net Property, Plant and Equip., 5 Yr. CAGR %	76.8	62.17	54.76	49.43	49.95
Total Assets, 5 Yr. CAGR %	35.63	31.51	26.89	20.13	19.75
Tangible Book Value, 5 Yr. CAGR %	12	28.32	37.89	33.1	32.93
Common Equity, 5 Yr. CAGR %	14.41	25.19	33.44	30.06	31.18
Cash From Operations, 5 Yr. CAGR %	67.7	53.35	34.35	5.44	106.71
Capital Expenditures, 5 Yr. CAGR %	61.46	53.23	26.52	47.03	25.98
Levered Free Cash Flow, 5 Yr. CAGR %	70.55	189.97	55	39.72	200.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	70.62	184.38	53.99	39.65	181.84
Dividend Per Share, 5 Yr. CAGR %	42.02	34.31	31.62	25.14	26.37